Acthar Gel Inhibits the Activation of CD4 + and CD8 + T Cells
Journal of Interferon & Cytokine Research · 2023
DOI: 10.1089/jir.2022.0257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2023. Verfasst von Dale Wright und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Pharmaceuticals, Bridgewater, New Jersey, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Interleukin-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several inflammatory diseases are characterized by elevated T cell counts and high pro-inflammatory cytokine levels. Inhibiting T cell activity may reduce tissue damage associated with these diseases. Acthar ® Gel has potent anti-inflammatory properties, yet little is known about its effect on T cells. This study compared the effects of Acthar, synthetic adrenocorticotropic hormone 1–24 (ACTH 1–24 ) depot, and prednisolone in a murine model of T cell activation. Assessments of CD4 + helper and CD8 + cytotoxic T cells and plasma concentrations of interferon-γ (IFN-γ), interleukin-2 (IL-2), and tumor necrosis factor-α (TNF-α) were made following anti-CD3-activation. Acthar significantly reduced the number of activated CD4 + and CD8 + T cells at amounts comparable to synthetic ACTH 1–24 depot or prednisolone. However, Acthar reduced production of IFN-γ, IL-2, and TNF-α significantly more than the other drugs, suggesting that the in vivo immunomodulatory effects of Acthar on T cells are distinct from synthetic ACTH 1–24 depot or prednisolone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mallinckrodt Pharmaceuticals, Bridgewater, New Jersey, USA.
Zitieren
APA
Wright, D., & Hayes, K. (2023). Acthar Gel Inhibits the Activation of CD4 + and CD8 + T Cells. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2022.0257
Vancouver
Wright D, Hayes K. Acthar Gel Inhibits the Activation of CD4 + and CD8 + T Cells. Journal of Interferon & Cytokine Research. 2023. doi:10.1089/jir.2022.0257
BibTeX
@article{Wright2023,
author = {Wright, Dale and Hayes, Kyle},
title = {Acthar Gel Inhibits the Activation of CD4 + and CD8 + T Cells},
journal = {Journal of Interferon & Cytokine Research},
year = {2023},
doi = {10.1089/jir.2022.0257}
}
EUVIMED